May 24, 2022 Journal article Open Access

Corbisier, Philippe; Petrillo, Mauro; Marchini, Antonio; Querci, Maddalena; Buttinger , Gerhard; Bekliz, Meriem; Spiesse, Katja; Polacek, Charlotta; Fomsgaard, Anders; Van den Eede, Guy

MARC21 XML Export

<?xml version='1.0' encoding='UTF-8'?>
<record xmlns="http://www.loc.gov/MARC21/slim">
  <leader>00000nam##2200000uu#4500</leader>
  <datafield tag="041" ind1=" " ind2=" ">
    <subfield code="a">eng</subfield>
  </datafield>
  <datafield tag="653" ind1=" " ind2=" ">
    <subfield code="a">COVID-19, Omicron, RT-PCR, detection method</subfield>
  </datafield>
  <controlfield tag="005">20220623135100.0</controlfield>
  <datafield tag="500" ind1=" " ind2=" ">
    <subfield code="a">DECLARATION The scientific output expressed does not imply a policy position of the European Commission. Neither the European Commission nor any person acting on behalf of the Commission is responsible for the use that might be made of this publication.</subfield>
  </datafield>
  <controlfield tag="001">6685159</controlfield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">Seidor Italy srl, Milano, Italy</subfield>
    <subfield code="0">(orcid)0000-0002-6782-4704</subfield>
    <subfield code="a">Petrillo, Mauro</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">European Commission, Joint Research Centre (JRC), Geel, Belgium</subfield>
    <subfield code="a">Marchini, Antonio</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">European Commission, Joint Research Centre (JRC), Ispra, taly</subfield>
    <subfield code="a">Querci, Maddalena</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">European Commission, Joint Research Centre (JRC), Geel, Belgium</subfield>
    <subfield code="a">Buttinger , Gerhard</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">Geneva Centre for Emerging Viral Diseases, Department of Microbiology and Molecular Medicine, University of Geneva, University Hospital Geneva (HUG), Switzerland</subfield>
    <subfield code="a">Bekliz, Meriem</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">Virus Research &amp; Development lab, Department of Virus &amp; Microbiologic Special Diagnostics, Statens Serum Institut, Denmark</subfield>
    <subfield code="a">Spiesse, Katja</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">Virus Research &amp; Development lab, Department of Virus &amp; Microbiologic Special Diagnostics, Statens Serum Institut, Denmark</subfield>
    <subfield code="a">Polacek, Charlotta</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">Virus Research &amp; Development lab, Department of Virus &amp; Microbiologic Special Diagnostics, Statens Serum Institut, Denmark</subfield>
    <subfield code="a">Fomsgaard, Anders</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">European Commission, Joint Research Centre (JRC), Geel, Belgium</subfield>
    <subfield code="a">Van den Eede, Guy</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2=" ">
    <subfield code="s">58814</subfield>
    <subfield code="z">md5:9cda69f83d220feb8edc11482714b93a</subfield>
    <subfield code="u">https://zenodo.org/record/6685159/files/Final.pdf</subfield>
  </datafield>
  <datafield tag="542" ind1=" " ind2=" ">
    <subfield code="l">open</subfield>
  </datafield>
  <datafield tag="260" ind1=" " ind2=" ">
    <subfield code="c">2022-05-24</subfield>
  </datafield>
  <datafield tag="909" ind1="C" ind2="O">
    <subfield code="p">openaire</subfield>
    <subfield code="p">user-covid-19</subfield>
    <subfield code="o">oai:zenodo.org:6685159</subfield>
  </datafield>
  <datafield tag="100" ind1=" " ind2=" ">
    <subfield code="u">European Commission, Joint Research Centre (JRC), Geel, Belgium</subfield>
    <subfield code="0">(orcid)0000-0002-4191-1391</subfield>
    <subfield code="a">Corbisier, Philippe</subfield>
  </datafield>
  <datafield tag="245" ind1=" " ind2=" ">
    <subfield code="a">A qualitative RT-PCR assay for the specific identification of the SARS-CoV-2 B.1.1.529 (Omicron) Variant of Concern</subfield>
  </datafield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">user-covid-19</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
    <subfield code="u">https://creativecommons.org/licenses/by/4.0/legalcode</subfield>
    <subfield code="a">Creative Commons Attribution 4.0 International</subfield>
  </datafield>
  <datafield tag="650" ind1="1" ind2="7">
    <subfield code="a">cc-by</subfield>
    <subfield code="2">opendefinition.org</subfield>
  </datafield>
  <datafield tag="520" ind1=" " ind2=" ">
    <subfield code="a">&lt;p&gt;&lt;em&gt;&lt;strong&gt;ABSTRACT&lt;/strong&gt;&lt;/em&gt;&lt;/p&gt;

&lt;p&gt;&lt;em&gt;Objectives&lt;/em&gt;: The aim of this study was to develop a RT-PCR assay for the specific detection of the SARS-CoV-2 Omicron Variant of Concern (VOC) as a rapid alternative to sequencing.&lt;/p&gt;

&lt;p&gt;&lt;em&gt;Methods&lt;/em&gt;: A RT-PCR was designed&amp;nbsp;&lt;em&gt;in silico&lt;/em&gt;&amp;nbsp;and then validated using characterised clinical samples containing Omicron (both BA.1 and BA.2 lineages) and the Omicron synthetic RNA genome. As negative controls, SARS-CoV-2 positive clinical samples collected in May 2020, and synthetic RNA genomes of the isolate Wuhan Hu-1 and of the Alpha (B.1.1.7), Beta (B.1.351), Gamma (P.1), Kappa (B.1.617.1), Iota (B.1.526), Epsilon (B.1.429) and Delta (B.1.617.2) SARS-CoV-2 VOC were used.&lt;/p&gt;

&lt;p&gt;&lt;em&gt;Results&lt;/em&gt;: Experiments performed using as templates the synthetic RNA genomes demonstrate the high specificity of the PCR-method for the SARS-CoV-2 Omicron. Despite the synthetic RNAs were used at high copy numbers, specific signal was mainly detected with the Omicron synthetic genome. Only a non-specific late signal was detected using the Alpha variant genome, but these results were considered negligible as Alpha VOC has been replaced by the Delta and it is not circulating anymore in the world. Using our method, we confirmed the presence of Omicron on clinical samples containing this variant but not of other SARS-CoV-2 lineages. The method is highly sensitive and can detect up to 1 cp of the Omicron virus per &amp;micro;l.&lt;/p&gt;

&lt;p&gt;&lt;em&gt;Conclusions&lt;/em&gt;: The method presented here, in combination with other methods in use for detection of SARS-CoV-2, can be used for an early identification of Omicron.&lt;/p&gt;</subfield>
  </datafield>
  <datafield tag="773" ind1=" " ind2=" ">
    <subfield code="n">doi</subfield>
    <subfield code="i">isVersionOf</subfield>
    <subfield code="a">10.5281/zenodo.5747871</subfield>
  </datafield>
  <datafield tag="024" ind1=" " ind2=" ">
    <subfield code="a">10.5281/zenodo.6685159</subfield>
    <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">publication</subfield>
    <subfield code="b">article</subfield>
  </datafield>
</record>